The efficacy and cost of aprotinin in children undergoing reoperative open heart surgery

Anesthesia and Analgesia
C C D'ErricoE L Bove

Abstract

We performed a prospective, randomized, placebo-controlled, double-blind trial to assess the efficacy of aprotinin in 61 children (median age 3.7 yr) undergoing reoperative open heart surgery (OHS). Three demographically similar groups were studied: large-dose aprotinin (ALD), small-dose aprotinin (ASD), and placebo (P). Over the first 24 postoperative hours fewer patients in the aprotinin groups received packed red cells (ALD, 53%; ASD, 89%; and P, 95%; P = 0.001), platelets (ALD, 32%; ASD, 50%; and P, 65%; P = 0.04), and fresh frozen plasma (ALD, 16%; ASD, 17%; and P, 60%; P = 0.003) than placebo patients. Most importantly, aprotinin patients had fewer exposures to banked blood components (ALD, median 1 U; and ASD, median 2 U) than P (median 6 U; P = 0.001), with no difference in overall complication rate. Use of aprotinin was associated with a savings in the patient charges for blood components, operating room time, and duration of hospitalization. In conclusion, aprotinin decreased the number of units of banked blood components used during the first 24 postoperative hours in reoperative pediatric OHS. Aprotinin thus decreases the risks associated with exposure to banked blood components and reduces hospital charges.

References

Jul 18, 1992·Lancet·B WüthrichS G Johansson
Dec 1, 1987·The Annals of Thoracic Surgery·W van OeverenC R Wildevuur
Jan 12, 1984·The New England Journal of Medicine·J W CurranT J Spira
Dec 28, 1995·The New England Journal of Medicine·E M LackritzL R Petersen
Nov 1, 1994·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·J F Hardy, S Bélisle
Dec 1, 1995·The Annals of Thoracic Surgery·P A PenkoskeW Gibb

❮ Previous
Next ❯

Citations

Jun 13, 2006·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Joanne GuayDominique Lasne
Jun 30, 2006·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·D PietriniM Piastra
Apr 10, 2003·The Annals of Thoracic Surgery·John M CostelloConstantine Mavroudis
Sep 2, 1998·The Annals of Thoracic Surgery·B E MillerJ H Levy
Oct 13, 1998·The Annals of Thoracic Surgery·G D WilliamsC Ramamoorthy
Oct 24, 2002·Current Opinion in Hematology·Jason ChiuThomas J Reid
Feb 4, 2009·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Esther S SchoutenCasper W Bollen
Feb 26, 2003·PharmacoEconomics·Prabashni Reddy, Jessica Song
May 6, 2010·Annals of Cardiac Anaesthesia·Yashwant S VermaSambhu N Das
Nov 21, 2007·The Journal of Thoracic and Cardiovascular Surgery·Carl L BackerConstantine Mavroudis
Nov 29, 2005·Anesthesiology Clinics of North America·Laura K Diaz, Dean B Andropoulos
Sep 5, 2008·Paediatric Anaesthesia·Glyn D WilliamsV Mohan Reddy
Jul 1, 1998·The Annals of Thoracic Surgery·C C D'Errico
Oct 22, 2013·Paediatric Anaesthesia·Zulfiqar AhmedMaria Zestos
Jul 1, 1998·The Annals of Thoracic Surgery·H Mössinger, W Dietrich
Jul 1, 1998·The Annals of Thoracic Surgery·P Pouard
Dec 17, 1998·Journal of Cardiothoracic and Vascular Anesthesia·G D WilliamsC Ramamoorthy
Jan 6, 2000·Journal of Cardiothoracic and Vascular Anesthesia·C C D'ErricoE L Bove
Jan 6, 2000·Journal of Cardiothoracic and Vascular Anesthesia·G D Williams, C Ramamoorthy
Jun 3, 2004·The Journal of Thoracic and Cardiovascular Surgery·William C OliverFrancisco J Puga
Oct 6, 1999·The Annals of Thoracic Surgery·M J RayM F O'Brien
Jul 7, 1999·Journal of Cardiothoracic and Vascular Anesthesia·L K Davies
May 9, 2007·Seminars in Cardiothoracic and Vascular Anesthesia·Emad B MossadJohn Apostolakis
Dec 4, 2004·International Anesthesiology Clinics·Theodore A Alston
Aug 20, 2003·Journal of Neurosurgery·Celia C D'ErricoKarin M Muraszko
Jan 11, 2008·Paediatric Anaesthesia·S Devi ChiravuriShobha Malviya
Mar 20, 2008·Anesthesia and Analgesia·Michael P Eaton
Oct 3, 2006·Current Opinion in Anaesthesiology·F F WagnerB Kubanek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.